Loop-mediated Isothermal Amplification Market

Loop-mediated Isothermal Amplification Market Overview for 2024 to 2034

The loop-mediated isothermal amplification market is expected to be valued at USD 110.6 million in 2024. The pace of progress for the market from 2024 to 2034 is expected to be normal, with a CAGR of 4.9%. By the end of the forecast period, the loop-mediated isothermal amplification industry value is slated to hit USD 178.4 million.

Attributes	Details
Loop-mediated Isothermal Amplification Market Value for 2024	USD 110.6 million
Projected Market Value for 2034	USD 178.4 million
Value-based CAGR of Market for 2024 to 2034	4.9%

Loop-mediated Isothermal Amplification Market Analysis

• Government initiatives related to genetic testing and DNA research encourage more LAMP procedures.
• With the rising threat of infectious diseases, LAMP is one procedure that is being invested into to aid in the identification of these diseases in individuals.
• LAMP is preferred to polymerase chain reaction (PCR) by certain researchers and medical professionals because of its rugged quality and lower sensitivity to inhibitors than PCR.

Loop-mediated Isothermal Amplification Market Trends

• Because of the low cost of the procedure, LAMP is emerging as a viable testing and diagnostic measure in developing and underdeveloped countries.
• LAMP is used not just for diagnosis and blood-related procedures but also for identifying bodily fluids.
• LAMP’s coupling with technology has yielded results for researchers, and thus, the infusion of technology is expected to keep the market outlook fresh.
• LAMP procedures are being combined with leading molecular approaches such as real-time detection and chip-based assays for improved performance.
• PCR is a major competitor to LAMP and is still the primary blood-testing procedure. The popularity of PCR constrains the growth of the market.
• LAMP lacks the versatility of PCR, which can be used for cloning and other blood-related procedures. Thus, LAMP’s rigid application serves to impede the progress of the market.
• LAMP as a procedure is still a developing science, and thus, the market suffers from a lack of awareness on the part of end-users.

Category-wise Outlook

Microfluidic technology rules the roost when it comes to the technology used in LAMP procedures. LAMP is predominantly applied for clinical diagnostics.

Easy Intermingling of Microfluidic Technology with LAMP Procedures Earns it the Vote of Confidence from Researchers

Microfluidic technology is expected to account for 63.8% of the market share by technology in 2024. Factors driving the growth of the microfluidic technology are:

• Microfluidic technology is easily compatible with LAMP procedures, and thus, the technology is being utilized increasingly by researchers.
• Microfluidic technology is handy in the identification of diseases like malaria and tuberculosis. With cases of such diseases rising, the need for microfluidic technology is more eminent than ever.

Attributes	Details
Top Technology	Microfluidic Technology
Market Share (2024)	63.8%

Burgeoning Importance of Clinical Diagnostics Reflected in the Loop-Mediated Isothermal Amplification Market

Clinical diagnostic application of loop-mediated isothermal amplification is anticipated to account for 63.8% of the market share in 2024. Some of the factors for the growth of clinical diagnostic application of loop-mediated isothermal amplification are:

• With the variety of diseases plaguing people around the world increasing, clinical diagnosis is growing in importance as a scientific measure. LAMP application for clinical diagnostics is helping scientists deal with the demand for diagnostics in a more efficient way.
• With the type of diseases affecting people mutating, clinical diagnostics helps identify and treat these diseases. LAMP procedures are aiding clinical diagnostic practitioners in identifying and working on various blood-related diseases.

Attributes	Details
Top Application	Clinical Diagnostics
Market Share (2024)	63.8%

Country-wise Analysis

The Asia Pacific is emerging as a hub for healthcare research, thus aiding the loop-mediated isothermal amplification’s cause in the region. The growing incidence of genetic disorders in the region is also positively affecting the market in the Asia Pacific.

Europe being at the forefront of healthcare technology is proving conducive to the market’s progress in the region. The European Union’s initiatives to control the spread of newer diseases is also helping the market’s cause in Europe.

Countries	CAGR (2024 to 2034)
China	5.3%
India	6.2%
United Kingdom	4.7%
Spain	5.6%
Italy	4.9%

Initiatives to Inculcate Research Studies Further into the Medical Field Propelling the Market in India

The market is anticipated to register a CAGR of 6.2% in India for the forecast period. Some of the factors driving the growth of the market in the country are:

• Government initiatives aiding research in India are helping along the market. Clinical diagnostics and other research-related fields are advancing rapidly in India and playing a more pivotal role in the healthcare sector. Thus, LAMP procedures are progressing along in the country.
• There is encouragement in India for research from all corners, from high-end companies to university level, and thus the market has wide scope in the country.

Widespread Use of LAMP in Virus-relate Disease Testing in the United Kingdom

The United Kingdom is set to see the market expand at a CAGR of 4.7% over the forecast period. Prominent factors driving the growth of the market are:

• Research institutions in the United Kingdom are taking the help of LAMP to produce diagnosis solutions for virus-related diseases like SARS and COVID-19.
• University-level research is being encouraged in the medical field in the United Kingdom. Bath University is one such university that has used LAMP to come up with new diagnostic capabilities.

China’s Robust Healthcare Sector Conducive to the Growth of the Market in the Country

The market is expected to register a CAGR of 5.3% in China during the forecast period. Some of the factors driving the growth of the market in China are:

• China’s humongous population necessitates the presence of an effective healthcare system. The healthcare system in China is fledging, and thus, research procedures like LAMP have an easy pathway in the country.
• China has been under the threat of developing new diseases in the recent past. Thus, procedures that help in the identification and research of these diseases, such as LAMP, are increasing in popularity in the country.

Increasing Investment in Healthcare Technology Leading to Market Acceleration in Spain

The market is set to progress at a CAGR of 5.6% in Spain during the forecast period. Factors influencing the growth of the market in Spain include:

• Both public and private investment in healthcare technology is growing in Spain, and thus, LAMP is finding an easy pathway towards progress in the country.
• A rising number of people with genetic conditions are spurring DNA testing in Spain, and the loop-mediated isothermal amplification market is benefiting.

Public Desire to Keep Infectious Diseases at Bay Molding the Market Positively in Italy

The market is expected to register a CAGR of 4.9% in Italy. Some of the reasons for the growth of loop-mediated isothermal amplification in the country are:

• Italy’s many coastal regions expose the country’s population to several water-borne diseases. Diagnostic procedures like LAMP are being utilized in the country to keep the threat of infectious diseases controlled.
• Low cost of LAMP is helping the procedure to make further headway into Italy, where the funding for research institutions has the potential to be sketchy.

Competitive Landscape in the Loop-mediated Isothermal Amplification Market

Since loop-mediated isothermal amplification is still a developing process, the market is currently being controlled by a few reputed names. However, as the knowledge about the procedure grows, new entrants are steadily making their way into the market.

Market players are collaborating with healthcare and research institutions to eradicate the lack of awareness about the procedure. Both public and private investment are being sought by market players in their bid to develop the procedure further.

Recent Developments in the Loop-mediated Isothermal Amplification Market

• In 2023, researchers at Bath University in England developed the LoCKAmp test, described as the fastest COVID test in the world, with the help of reverse transcription loop-mediated isothermal amplification.
• Also in 2023, scientists from the University of Surrey, Brunel University London, and Lancaster University, along with the NHS, GB Electronics (UK) Ltd., and Vidiia Ltd., developed the VIDIIA Hunter (VH6) platform for infectious disease testing. It combines RT-LAMP with AI.
• In August 2022, LGC Clinical Diagnostics’ collaboration with Stanford Medicine's Department of Obstetrics and Gynecology and Metabolic Health Center was extended.

Key Companies in the Loop-mediated Isothermal Amplification Market

• Jena Bioscience GmbH
• HiberGene Diagnostics
• Meridian Bioscience, Inc.
• Mast Group Ltd.
• Excellgen, Inc.
• Merck KGaA
• QIAGEN N.V
• NIPPON GENE CO., LTD
• New England Biolabs
• Bio-Rad Laboratories, Inc.
• Thermo Fisher Scientific

Key Coverage in the Loop-mediated Isothermal Amplification Industry Report

• isothermal nucleic acid amplification technology market covergae
• Loop-mediated isothermal amplification (LAMP) market revenue analysis
• INAAT Market Share & Size Assessment
• LAMP Technique Coverage
• LAMP Assay Market Report
• LAMP and PCR Market Comparative Analysis

Table of Content

• 1. Executive Summary
• 2. Market Overview
• 3. Market Background
• 4. Global Market Analysis 2019 to 2023 and Forecast, 2024 to 2034
• 5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Product
  • 5.1. Instruments
    • 5.1.1. Incubation Systems
    • 5.1.2. Turbidimeter
    • 5.1.3. Agarose Gel Electrophoresis
    • 5.1.4. Fluorescence Measuring Systems
  • 5.2. Kits & Reagents
    • 5.2.1. DNA Polymerase
    • 5.2.2. Primer Mix
    • 5.2.3. DNA Polymerase & Primer Mix
    • 5.2.4. Dyes
    • 5.2.5. Others
• 6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Technology
  • 6.1. Microfluidic Technology
  • 6.2. Advanced Infrared Optical Technology
  • 6.3. Modern Microsystem Technology
• 7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Application
  • 7.1. Diagnostic Purposes
  • 7.2. Research Purposes
• 8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By End User
  • 8.1. Hospital Laboratories
  • 8.2. Research and Academic Institutes
  • 8.3. Diagnostic Centres
• 9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region
  • 9.1. North America
  • 9.2. Latin America
  • 9.3. Western Europe
  • 9.4. Eastern Europe
  • 9.5. South Asia and Pacific
  • 9.6. East Asia
  • 9.7. Middle East and Africa
• 10. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
• 11. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
• 12. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
• 13. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
• 14. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
• 15. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
• 16. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
• 17. Key Countries Market Analysis
• 18. Market Structure Analysis
• 19. Competition Analysis
  • 19.1. Jena Bioscience GmbH
  • 19.2. HiberGene Diagnostics
  • 19.3. Meridian Bioscience, Inc.
  • 19.4. Mast Group Ltd.
  • 19.5. Excellgen, Inc.
  • 19.6. Merck KGaA
  • 19.7. QIAGEN N.V
  • 19.8. NIPPON GENE CO., LTD
  • 19.9. New England Biolabs
  • 19.10. Bio-Rad Laboratories, Inc.
  • 19.11. Thermo Fisher Scientific
• 20. Assumptions & Acronyms Used
• 21. Research Methodology